Related Experiment Videos

Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs

G Jansen1, M Mahadevan, C Amemiya

  • 1Department of Cell Biology and Histology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Nature Genetics
|July 1, 1992
PubMed

Insights

Myotonic dystrophy (DM) is linked to expanded CTG-repeats in the DM-kinase gene. This mutation may disrupt alternative RNA splicing of DM-kinase or the nearby DMR-N9 gene, causing disease symptoms.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Myotonic dystrophy (DM) is a genetic disorder characterized by muscle weakness and wasting.
  • The underlying genetic mutation involves an expanded CTG-repeat sequence.
  • The DM-kinase (DMR-B15) gene, encoding protein kinase activity, is implicated in DM pathogenesis.

Purpose of the Study:

  • To investigate the role of the CTG-repeat expansion in DM pathogenesis.
  • To characterize the DM-kinase (DMR-B15) and a nearby gene (DMR-N9) in humans and mice.
  • To explore the impact of the mutation on alternative RNA splicing.

Main Methods:

  • Analysis of CTG-repeat expansion in the DM-kinase gene.
  • Characterization of DM-kinase (DMR-B15) and DMR-N9 gene transcripts in human and mouse.
  • Investigation of alternative RNA splicing patterns.

Main Results:

  • The mutation in DM is an expansion of a polymorphic CTG-repeat in the DM-kinase gene.
  • DM-kinase (DMR-B15) transcripts undergo alternative RNA splicing in both humans and mice.
  • A neighboring gene, DMR-N9, is also identified and expressed in brain and testis, with unknown protein function.

Conclusions:

  • The expanded CTG-repeat in DM may impair the alternative expression of DM-kinase or DMR-N9 proteins.
  • Alternative RNA splicing of these genes is a key factor in DM pathology.
  • Further research is needed to elucidate the function of DMR-N9 and its role in DM.

Related Concept Videos